Order Entry
Canada
ContactUsLinkComponent
HIV Protease FRET Substrate I, DABCYL-EDANS
HIV Protease FRET Substrate I, DABCYL-EDANS
Catalog # 102996-366
Supplier:  Anaspec Inc
CAS Number:  
HIV Protease FRET Substrate I, DABCYL-EDANS
Catalog # 102996-366
Supplier:  Anaspec Inc
Supplier Number:  AS-22992
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products, please provide identification that includes your business name and shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of identification are:

  • • Issued document with your organization's Federal Tax ID Number
  • • Government issued document with your organization's Resale Tax ID Number
  • • Any other Government ID that includes the business name and address

Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Conjugation:
    DABCYL-EDANS
  • Size:
    1 mg
  • Storage conditions:
    –20 °C
  • Protein synonyms:
    HIV protease substrate
  • Protein/peptide name:
    HIV Protease FRET Substrate I
  • Purity:
    95%
  • Molecular weight:
    1532.5 Da
  • Sequence:
    DABCYL-GABA-SQNYPIVQ-EDANS
  • Cat. no.:
    102996-366
  • Supplier No.:
    AS-22992

Specifications

About this item

DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS is also called HIV protease substrate I in some literature. It is widely used for the continuous assay for HIV protease activity. The 11-kD protease (PR) encoded by the human immunodeficiency virus 1 (HIV-1) is essential for the correct processing of viral polyproteins and the maturation of infectious virus, and is therefore a target for the design of selective acquired immunodeficiency syndrome (AIDS) therapeutics. The FRET-based fluorogenic substrate is derived from a natural processing site for HIV-1 PR. Incubation of recombinant HIV-1 PR with the fluorogenic substrate resulted in specific cleavage at the Tyr-Pro bond and a time-dependent increase in fluorescence intensity that is linearly related to the extent of substrate hydrolysis. The fluorescence quantum yields of the HIV-1 PR substrate in the FRET assay increased by 40.0- and 34.4-fold, respectively, per mole of substrate cleaved. Because of its simplicity and precision in the determination of reaction rates required for kinetic analysis, this substrate offers many advantages over the commonly used HPLC or electrophoresis-based assays for peptide substrate hydrolysis by retroviral PRs. Abs/Em = 340nm/490nm.
Sequence:DABCYL-GABA-SQNYPIVQ-EDANS
MW:1532.5 Da
% peak area by HPLC:95
Storage condition:-20° C